Report Detail
(Post-pandemic Era)-Global Long-Acting Injectables Market Segment Research Report 2022
- RnM4476573 |
- 04 August, 2022 |
- Global |
- 103 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Long-Acting Injectables Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Long-Acting Injectables industry at home and abroad, estimate the overall market scale of the Long-Acting Injectables industry and the market share of major countries, Long-Acting Injectables industry, and study and judge the downstream market demand of Long-Acting Injectables through systematic research, Analyze the competition pattern of Long-Acting Injectables, so as to help solve the pain points of various stakeholders in Long-Acting Injectables industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Long-Acting Injectables Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Long-Acting Injectables Market?
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Major Type of Long-Acting Injectables Covered in XYZResearch report:
Small and Middle Sized Molecule
Large Sized Molecule
Application Segments Covered in XYZResearch Market
Schizophrenia
Other Psychotic Disorders
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Long-Acting Injectables Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Long-Acting Injectables Market by Value
- 2.2.1 Global Long-Acting Injectables Revenue by Type
- 2.2.2 Global Long-Acting Injectables Market by Value (%)
- 2.3 Global Long-Acting Injectables Market by Production
- 2.3.1 Global Long-Acting Injectables Production by Type
- 2.3.2 Global Long-Acting Injectables Market by Production (%)
3. The Major Driver of Long-Acting Injectables Industry
- 3.1 Historical & Forecast Global Long-Acting Injectables Demand
- 3.2 Largest Application for Long-Acting Injectables (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Long-Acting Injectables Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Long-Acting Injectables Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Long-Acting Injectables Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Long-Acting Injectables Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Long-Acting Injectables Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Long-Acting Injectables Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Long-Acting Injectables Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Long-Acting Injectables Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Long-Acting Injectables Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Long-Acting Injectables Average Price Trend
- 12.1 Market Price for Each Type of Long-Acting Injectables in US (2018-2022)
- 12.2 Market Price for Each Type of Long-Acting Injectables in Europe (2018-2022)
- 12.3 Market Price for Each Type of Long-Acting Injectables in China (2018-2022)
- 12.4 Market Price for Each Type of Long-Acting Injectables in Japan (2018-2022)
- 12.5 Market Price for Each Type of Long-Acting Injectables in India (2018-2022)
- 12.6 Market Price for Each Type of Long-Acting Injectables in Korea (2018-2022)
- 12.7 Market Price for Each Type of Long-Acting Injectables in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Long-Acting Injectables Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Long-Acting Injectables
14. Long-Acting Injectables Competitive Landscape
- 14.1 Eli Lilly
- 14.1.1 Eli Lilly Company Profiles
- 14.1.2 Eli Lilly Product Introduction
- 14.1.3 Eli Lilly Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Pfizer
- 14.2.1 Pfizer Company Profiles
- 14.2.2 Pfizer Product Introduction
- 14.2.3 Pfizer Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 GlaxoSmithKline
- 14.3.1 GlaxoSmithKline Company Profiles
- 14.3.2 GlaxoSmithKline Product Introduction
- 14.3.3 GlaxoSmithKline Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Johnson & Johnson
- 14.4.1 Johnson & Johnson Company Profiles
- 14.4.2 Johnson & Johnson Product Introduction
- 14.4.3 Johnson & Johnson Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Lupin
- 14.5.1 Lupin Company Profiles
- 14.5.2 Lupin Product Introduction
- 14.5.3 Lupin Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Zogenix
- 14.6.1 Zogenix Company Profiles
- 14.6.2 Zogenix Product Introduction
- 14.6.3 Zogenix Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 DURECT
- 14.7.1 DURECT Company Profiles
- 14.7.2 DURECT Product Introduction
- 14.7.3 DURECT Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Medincel
- 14.8.1 Medincel Company Profiles
- 14.8.2 Medincel Product Introduction
- 14.8.3 Medincel Long-Acting Injectables Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Long-Acting Injectables. Industry analysis & Market Report on Long-Acting Injectables is a syndicated market report, published as (Post-pandemic Era)-Global Long-Acting Injectables Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Long-Acting Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
